ENVESTNET ASSET MANAGEMENT INC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 84 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2023$234,247
+1996.0%
14,214
-58.3%
0.00%
Q1 2023$11,176
-83.6%
34,056
+150.1%
0.00%
Q3 2022$68,000
+106.1%
13,619
-0.2%
0.00%
Q2 2022$33,000
-64.1%
13,645
+1.5%
0.00%
Q1 2022$92,000
-41.8%
13,443
-31.1%
0.00%
Q4 2021$158,000
+20.6%
19,508
+46.2%
0.00%
Q3 2021$131,000
+45.6%
13,339
+0.2%
0.00%
Q2 2021$90,000
+55.2%
13,316
+15.4%
0.00%
Q3 2020$58,000
-34.1%
11,543
+6.3%
0.00%
Q2 2020$88,000
+41.9%
10,855
-27.4%
0.00%
Q3 2019$62,000
+40.9%
14,951
-1.4%
0.00%
Q2 2019$44,000
+175.0%
15,158
+39.1%
0.00%
Q1 2019$16,000
-40.7%
10,899
+2.5%
0.00%
Q4 2018$27,000
+285.7%
10,637
+870.5%
0.00%
Q2 2018$7,000
-12.5%
1,0960.0%0.00%
Q1 2018$8,000
-33.3%
1,096
-28.0%
0.00%
Q4 2017$12,000
+140.0%
1,523
+196.9%
0.00%
Q3 2017$5,000
-16.7%
513
-4.8%
0.00%
Q2 2017$6,000
+20.0%
539
-1.1%
0.00%
Q1 2017$5,0005450.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders